Insider Trading Activity For Bristol-Myers Squibb Company (NYSE:BMY)
Theodore R Samuels II , Director of Bristol-Myers Squibb Company (NYSE:BMY) reportedly Bought 6,000 shares of the company’s stock at an average price of 55.94 for a total transaction amount of $335,640.00 SEC Form
Insider Trading History For Bristol-Myers Squibb Company (NYSE:BMY)
Analyst Ratings For Bristol-Myers Squibb Company (NYSE:BMY)
These are 1 Sell Rating, 10 Hold Ratings, 10 Buy Ratings .
The current consensus rating for Bristol-Myers Squibb Company (NYSE:BMY) is Hold (Score: 2.43) with a consensus target price of $63.00 , a potential (13.51% upside)
Analyst Ratings History For Bristol-Myers Squibb Company (NYSE:BMY)
- On 12/2/2015 Guggenheim Upgraded rating Neutral to Buy with a price target of $82.00
- On 12/18/2015 Atlantic Securities Initiated Coverage of rating Underweight with a price target of $57.00
- On 4/6/2016 Societe Generale Initiated Coverage of rating Sell with a price target of $48.00
- On 8/11/2016 Sanford C. Bernstein Reiterated Rating Market Perform with a price target of $79.00 to $65.00
- On 8/11/2016 Berenberg Bank Downgraded rating Buy to Hold with a price target of $80.00 to $70.00
- On 8/25/2016 Morgan Stanley Reiterated Rating Neutral to Hold
- On 10/10/2016 SunTrust Banks, Inc. Reiterated Rating Hold with a price target of $68.00 to $62.00
Dividend Information For Bristol-Myers Squibb Company (NYSE:BMY)
Bristol-Myers Squibb Company (NYSE:BMY) pays an annual dividend of Community Ranking: with a yield of 2.81% and an average dividend growth of 2.80% (3 Year Average).
Dividend History For Bristol-Myers Squibb Company (NYSE:BMY)
Recent Trading Activity for Bristol-Myers Squibb Company (NYSE:BMY)
Shares of Bristol-Myers Squibb Company closed the previous trading session at 55.50 up +0.27 0.49% with 5,463,021 shares trading hands.